[시장보고서]장시간 작용형 약물전달 기술 및 서비스 시장 : 부문별, 국가별, 지역별

장시간 작용형 약물전달 기술 및 서비스 시장 : 부문별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Long-Acting Drug Delivery Technologies and Services Market, By Material, By Dosage Form, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

상품코드 : 1555490

리서치사 : AnalystView Market Insights

발행일 : 2024년 08월

페이지 정보 : 영문 386 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,250

￦ 4,705,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650

￦ 6,732,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,180,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

보고서 하이라이트

장시간 작용형 약물전달 기술 및 서비스(Long-Acting Drug Delivery Technologies and Services) 시장 규모는 2023년에 122억 3,423만 달러였으며, 2024년부터 2032년에 걸쳐 CAGR 11.2%로 추이하며 확대 될 것으로 예상

장시간 작용형 약물전달 기술 및 서비스 시장-시장 역학

환자의 복약 준수의 향상과 고혈압증, 정신질환의 유행이 시장 수요를 촉진할 전망

당뇨병, 고혈압, 암, 정신 질환은 점점 흔해지고 있으며 종종 장기 관리가 필요합니다. 장시간 작용형 제형은 투여 횟수를 줄이고 환자의 복약 충동을 향상시키기 때문에 시장 성장을 뒷받침할 것으로 기대됩니다. 예방의료가 중시되게 되어 왔으며, 이것은 장시간 작용형 약제를 사용하여 증상이 중증화되기 전에 관리함으로써 생활의 질을 향상시키고 장기적인 의료비를 줄이는 것도 포함됩니다.

생물제제와 바이오시밀러의 장시간 작용형 제제의 개발이 시장을 확대하고 있습니다. 이러한 의약품은 장기간 안정성과 효능을 유지하기 위해 복잡한 전달 시스템을 필요로 합니다. 나노기반 약물전달 시스템, 고급 폴리머, 제제화 기술의 향상 등 의약품 기술의 혁신으로 장시간 작용형 약물전달 시스템은 보다 효과적이고 다재다능한 것이 되고 있습니다. 복용 횟수와 복용 빈도 감소로 인한 편의성 향상은 환자의 치료 계획 준수를 촉진하여 건강 상태 개선 및 의료비 절감으로 이어집니다. 이러한 모든 이점이 시장 성장에 기여할 것으로 예상되었습니다.

장시간 작용형 약물전달 기술 및 서비스 시장-주요 인사이트

리서치 애널리스트 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 CAGR 약 11.2%로 성장할 것으로 추정됩니다.

재료별 부문은 장시간 작용형 약물전달에 있어서 높은 효율성으로 인해 폴리머 기반 부문이 2023년에 가장 큰 시장 점유율을 나타냈습니다.

투여 형태별로, 장시간 작용형 주사제는 약물전달에 있어서 큰 효과와 신속한 반응에 의해 2023년에 주요 투여 형태가 되었습니다.

최종 사용자 부문을 기반으로 제약 및 바이오 산업의 의약품 수요가 높기 때문에 제약 및 바이오 기업 부문이 2023년 주요 최종 사용자 부문이였습니다.

지역별로는 정부&FDA의 지원에 의해 북미가 2023년에 수익으로 리드했습니다.

장시간 작용형 약물전달 기술 및 서비스 시장-세분화 분석 :

장시간 작용형 약물전달 기술 및 서비스 세계 시장은 재료, 투여 형태, 최종 사용자, 지역에 따라 구분됩니다.

폴리머베이스와 비 폴리머베이스입니다. 폴리머 기반 부문이 시장을 독점하고 있습니다. 폴리머 기반 약제은 장시간 작용하기 때문에 시장에서 견인력이 높아지고 있습니다.

제형별로는 장시간 작용형 주사제, 장시간 작용형 이식형 주사제, 장시간 작용형 경구제 등으로 분류됩니다. 장시간 작용형 주사제는 시장을 독점합니다. 주사제는 일반적인 호흡기 질환에 높은 효과를 발휘하기 때문에 이 분야의 성장에 박차를 가하고 있습니다.

시장은 최종 사용자별로 제약·바이오기업, 연구개발, 기타 3가지로 분류됩니다. 제약·바이오테크놀러지 기업이 시장을 독점하고 있으며, 예측 기간 동안에도 높은 우위성을 유지할 것으로 예상됩니다. 의약품 개발과 제약 기술 증가가 시장 수요를 밀어 올리고 있습니다.

장시간 작용형 약물전달 기술 및 서비스 시장-지리적 통찰력

지역적으로, 이 시장은 북미, 중남미, 유럽, 아시아 태평양, 중동 및 아프리카에 퍼져 있습니다. 미국은 고급 의료 인프라, 신기술의 높은 채택률, 충실한 R&D 투자로 세계 시장에서 큰 점유율을 차지하고 있습니다. 유럽은 맞춤형 의료 및 고급 약물전달 시스템에 중점을 둔 주요 시장입니다. 주요 시장에는 독일, 프랑스, 영국이 포함됩니다. 중남미는 의료 접근이 확대되고 의료 인프라에 대한 투자가 증가하고 있는 신흥 시장입니다.

장시간 작용형 약물전달 기술 및 서비스 시장-경쟁 환경 :

장시간 작용형 약물전달 기술 및 서비스 시장은 큰 경쟁과 지속적인 혁신을 특징으로 합니다. 이 분야의 기업들은 기술적 진보, 제휴, 협력, 시장 확대 등 다양한 전략을 추진하고 있습니다. 기업은 장시간 작용형 약물전달 시스템을 강화하기 위해 나노기술, 생분해성 폴리머, 첨단 마이크로스피어 기술에 투자하고 있습니다. 제약회사, 기술기업, 학술기관 간의 전략적 파트너십은 장시간 작용형 약물전달 기술을 발전시키고 시장 범위를 확대하는 데 매우 중요합니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아 태평양(APAC)
- 개요
- 아시아 태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
남미
- 개요
- 남미의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석-장시간 작용형 약물전달 기술 및 서비스 산업

경쟁 대시보드
기업 프로파일
- Pfizer Inc.
- Roche Holding AG
- Novartis International AG
- Johnson &Johnson
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Viatris Inc.
- ALZA Corporation
- Eli Lilly and Company
- Merck &Co., Inc.
- Sanofi SA
- AbbVie Inc.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- AstraZeneca plc
- 기타

제12장 애널리스트의 전방위 전망

LYJ

영문 목차

영문목차

REPORT HIGHLIGHT

Long-Acting Drug Delivery Technologies and Services Market size was valued at USD 12,234.23 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Long-Acting Drug Delivery Technologies and Services imply advanced methods and systems designed to administer medications over extended periods with fewer doses compared to traditional methods. These technologies aim to improve patient adherence, enhance therapeutic efficacy, and reduce the frequency of administration.

Long-Acting Drug Delivery Technologies and Services Market- Market Dynamics

Increasing patient adherence and the prevalence of hypertension, and psychiatric diseases are expected to propel market demand

Diabetes, hypertension, cancer, and psychiatric disorders are increasingly common and often require long-term management. Long-acting formulations reduce the frequency of dosing and improve patient adherence which is expected to bolster market growth. There is a growing emphasis on preventive healthcare, which includes using long-acting medications to manage conditions before they become severe, thereby improving quality of life and reducing long-term healthcare costs.

The development of long-acting formulations for biologics and biosimilars is expanding the market. These drugs often require complex delivery systems to maintain stability and effectiveness over time. Innovations in pharmaceutical technology, such as nano-based drug delivery systems, advanced polymers, and improved formulation techniques, are making long-acting drug delivery systems more effective and versatile. Enhanced convenience from fewer doses and less frequent administration encourages patients to stick to their treatment plans, which can lead to better health outcomes and reduced healthcare costs. All these benefits are projected to contribute to market growth.

Long-Acting Drug Delivery Technologies and Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Material segmentation, the polymer-based segment was predicted to show maximum market share in the year 2023, owing to its high efficiency in long-acting drug delivery.

Based on Dosage Form segmentation, long acting injectables segment was the leading Dosage Form in 2023, owing to its greater effects in drug delivery & quick response.

Based on End User segmentation, the pharmaceutical & biotech companies' segment was the leading End User segment in 2023, owing to the high demand for drugs in the pharma & biotech industries.

Based on region, North America was the leading revenue generator in 2023, due to the government & FDA support.

Long-Acting Drug Delivery Technologies and Services Market- Segmentation Analysis:

The Global Long-Acting Drug Delivery Technologies and Services Market is segmented based on Material, Dosage Form, End User, and Region.

The market is divided into two categories based on Material: polymer-based and non-polymer based. The polymer-based segment dominates the market. Polymer-based drugs provide long-acting durability and thus are gaining more traction in the market.

The market is divided into four categories based on Dosage Form: long acting injectables, acting implantables, long-acting oral, and others. The long acting injectables segment dominates the market. Injectables have high efficiency in common respiratory disorders which is fueling segment growth.

The market is divided into three categories based on End Users: pharmaceutical & biotech companies, research & development, and others. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing number of drug development and pharma technologies are boosting market demand.

Long-Acting Drug Delivery Technologies and Services Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The United States holds a significant share of the global market due to advanced healthcare infrastructure, high adoption rates of new technologies, and substantial R&D investments. Europe is a major market with a growing emphasis on personalized medicine and advanced drug delivery systems. Key markets include Germany, France, and the UK. Latin America is an emerging market with expanding healthcare access and increasing investments in healthcare infrastructure.

Long-Acting Drug Delivery Technologies and Services Market- Competitive Landscape:

The long-acting drug delivery technologies and services market is characterized by significant competition and ongoing innovations. Companies in this space are engaged in various strategies, including technological advancements, partnerships, collaboration, and market expansions. Companies are investing in nanotechnology, biodegradable polymers, and advanced microsphere technologies to enhance long-acting drug delivery systems. Strategic partnerships between pharmaceutical companies, technology firms, and academic institutions are crucial for advancing long-acting drug delivery technologies and expanding market reach.

Recent Developments:

In February 2023, EyePoint Pharmaceuticals and Rallybio formed a research agreement to assess Rallybio's inhibitors of complement component 5 (C5) using Durasert(R) technology.

In April 2023, the U.S. FDA approved ABILIFY ASIMTUFII, a long-acting injectable suspension, developed by Otsuka, administered intramuscularly once every two months for the treatment of schizophrenia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET KEY PLAYERS

Pfizer Inc.
Roche Holding AG
Novartis International AG
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Viatris Inc.
ALZA Corporation
Eli Lilly and Company
Merck & Co., Inc.
Sanofi S.A.
AbbVie Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
AstraZeneca plc
Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY MATERIAL- MARKET ANALYSIS, 2019-2032

Polymer-based
Non-polymer Based

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019-2032

Long Acting Injectables
Long Acting Implantable
Long-acting Oral
Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Pharmaceutical & Biotech Companies
Research & Development
Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Long-Acting Drug Delivery Technologies and Services Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Long-Acting Drug Delivery Technologies and Services Market Snippet by Material
- 2.1.2. Long-Acting Drug Delivery Technologies and Services Market Snippet by Dosage Form
- 2.1.3. Long-Acting Drug Delivery Technologies and Services Market Snippet by End User
- 2.1.4. Long-Acting Drug Delivery Technologies and Services Market Snippet by Country
- 2.1.5. Long-Acting Drug Delivery Technologies and Services Market Snippet by Region
2.2. Competitive Insights

3. Long-Acting Drug Delivery Technologies and Services Key Market Trends

3.1. Long-Acting Drug Delivery Technologies and Services Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Long-Acting Drug Delivery Technologies and Services Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Long-Acting Drug Delivery Technologies and Services Market Opportunities
3.4. Long-Acting Drug Delivery Technologies and Services Market Future Trends

4. Long-Acting Drug Delivery Technologies and Services Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Long-Acting Drug Delivery Technologies and Services Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Long-Acting Drug Delivery Technologies and Services Market Landscape

6.1. Long-Acting Drug Delivery Technologies and Services Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Long-Acting Drug Delivery Technologies and Services Market - By Material

7.1. Overview
- 7.1.1. Segment Share Analysis, By Material, 2024 & 2032 (%)
- 7.1.2. Polymer-based
- 7.1.3. Non-polymer Based

8. Long-Acting Drug Delivery Technologies and Services Market - By Dosage Form

8.1. Overview
- 8.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
- 8.1.2. Long Acting Injectables
- 8.1.3. Long Acting Implantable
- 8.1.4. Long-acting Oral
- 8.1.5. Others

9. Long-Acting Drug Delivery Technologies and Services Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Pharmaceutical & Biotech Companies
- 9.1.3. Research & Development
- 9.1.4. Others

10. Long-Acting Drug Delivery Technologies and Services Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Long-Acting Drug Delivery Technologies and Services Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Pfizer Inc.
- 11.2.2. Roche Holding AG
- 11.2.3. Novartis International AG
- 11.2.4. Johnson & Johnson
- 11.2.5. Boehringer Ingelheim
- 11.2.6. Bristol-Myers Squibb
- 11.2.7. Viatris Inc.
- 11.2.8. ALZA Corporation
- 11.2.9. Eli Lilly and Company
- 11.2.10. Merck & Co., Inc.
- 11.2.11. Sanofi S.A.
- 11.2.12. AbbVie Inc.
- 11.2.13. Gilead Sciences, Inc.
- 11.2.14. GlaxoSmithKline plc
- 11.2.15. AstraZeneca plc
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us